Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
Nasdaq 100 futures outperformed with nearly a 1% rally, while S&P 500 futures trended higher as well. Dow Jones futures ...
Global interest rates are set to remain higher for longer, with Bloomberg Economics forecasting borrowing costs elevated by ...
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results